Changes in Mycobacterium tuberculosis-Specific Immunity With Influenza co-infection at Time of TB Diagnosis

Prior Influenza A viral (IAV) infection has been shown to increase susceptibility to tuberculosis (TB) and TB has also been shown to be a primary cause of death during pandemics, including the Spanish Influenza outbreak of 1918-1919. The majority of data has been obtained from mouse models, thus the...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in immunology Vol. 9; p. 3093
Main Authors Mendy, Joseph, Jarju, Sheikh, Heslop, Rhiannon, Bojang, Adama L., Kampmann, Beate, Sutherland, Jayne S.
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 04.01.2019
Subjects
Online AccessGet full text
ISSN1664-3224
1664-3224
DOI10.3389/fimmu.2018.03093

Cover

Abstract Prior Influenza A viral (IAV) infection has been shown to increase susceptibility to tuberculosis (TB) and TB has also been shown to be a primary cause of death during pandemics, including the Spanish Influenza outbreak of 1918-1919. The majority of data has been obtained from mouse models, thus the aim of this study was to determine the impact of Flu co-infection on host immunity and disease severity in TB patients at diagnosis. Sputum from 282 patients with active TB were analyzed for presence of FluA/FluB RNA at presentation using multiplex PCR. Sputum RNA was also analyzed for (Mtb) load using S RNA amplification. Supernatants from digested sputum and Mtb antigen-stimulated whole blood were analyzed using multiplex cytokine arrays and PBMC were analyzed for cytokine production from CD4+ T, CD8+ T and Mucosal Associated Invariant T cells (MAITs). 12 (4.3%) of TB patients were found to have FluA or FluB viral RNA present in their sputum at the time of TB diagnosis. The TB/Flu co-infected patients had a significantly higher bacterial load compared to those with TB mono-infection ( = 0.0026). They had lower levels of IL17A in sputum ( = 0.0275) and higher MCP-1 (CCL2) levels in the blood following PPD stimulation ( = 0.0267). TB/Flu co-infected subjects had significantly higher IFN-γ+IL-17+CD4+ and IFN-γ+IL-17-CD8+ cells compared to TB mono-infected subjects. These data show that Flu co-infection at time of TB diagnosis is associated with a higher bacterial load and differential cellular and soluble profiles. These findings show for the first time the impact of TB/Flu co-infection in a human cohort and support the potential benefit of Flu vaccination in TB-endemic settings.
AbstractList Background: Prior Influenza A viral (IAV) infection has been shown to increase susceptibility to tuberculosis (TB) and TB has also been shown to be a primary cause of death during pandemics, including the Spanish Influenza outbreak of 1918-1919. The majority of data has been obtained from mouse models, thus the aim of this study was to determine the impact of Flu co-infection on host immunity and disease severity in TB patients at diagnosis. Methods: Sputum from 282 patients with active TB were analyzed for presence of FluA/FluB RNA at presentation using multiplex PCR. Sputum RNA was also analyzed for Mycobacterium tuberculosis (Mtb) load using 16S RNA amplification. Supernatants from digested sputum and Mtb antigen-stimulated whole blood were analyzed using multiplex cytokine arrays and PBMC were analyzed for cytokine production from CD4+ T, CD8+ T and Mucosal Associated Invariant T cells (MAITs). Results: 12 (4.3%) of TB patients were found to have FluA or FluB viral RNA present in their sputum at the time of TB diagnosis. The TB/Flu co-infected patients had a significantly higher bacterial load compared to those with TB mono-infection (p = 0.0026). They had lower levels of IL17A in ex vivo sputum (p = 0.0275) and higher MCP-1 (CCL2) levels in the blood following PPD stimulation (p = 0.0267). TB/Flu co-infected subjects had significantly higher IFN-γ+IL-17+CD4+ and IFN-γ+IL-17-CD8+ cells compared to TB mono-infected subjects. Conclusions: These data show that Flu co-infection at time of TB diagnosis is associated with a higher bacterial load and differential cellular and soluble profiles. These findings show for the first time the impact of TB/Flu co-infection in a human cohort and support the potential benefit of Flu vaccination in TB-endemic settings.Background: Prior Influenza A viral (IAV) infection has been shown to increase susceptibility to tuberculosis (TB) and TB has also been shown to be a primary cause of death during pandemics, including the Spanish Influenza outbreak of 1918-1919. The majority of data has been obtained from mouse models, thus the aim of this study was to determine the impact of Flu co-infection on host immunity and disease severity in TB patients at diagnosis. Methods: Sputum from 282 patients with active TB were analyzed for presence of FluA/FluB RNA at presentation using multiplex PCR. Sputum RNA was also analyzed for Mycobacterium tuberculosis (Mtb) load using 16S RNA amplification. Supernatants from digested sputum and Mtb antigen-stimulated whole blood were analyzed using multiplex cytokine arrays and PBMC were analyzed for cytokine production from CD4+ T, CD8+ T and Mucosal Associated Invariant T cells (MAITs). Results: 12 (4.3%) of TB patients were found to have FluA or FluB viral RNA present in their sputum at the time of TB diagnosis. The TB/Flu co-infected patients had a significantly higher bacterial load compared to those with TB mono-infection (p = 0.0026). They had lower levels of IL17A in ex vivo sputum (p = 0.0275) and higher MCP-1 (CCL2) levels in the blood following PPD stimulation (p = 0.0267). TB/Flu co-infected subjects had significantly higher IFN-γ+IL-17+CD4+ and IFN-γ+IL-17-CD8+ cells compared to TB mono-infected subjects. Conclusions: These data show that Flu co-infection at time of TB diagnosis is associated with a higher bacterial load and differential cellular and soluble profiles. These findings show for the first time the impact of TB/Flu co-infection in a human cohort and support the potential benefit of Flu vaccination in TB-endemic settings.
Prior Influenza A viral (IAV) infection has been shown to increase susceptibility to tuberculosis (TB) and TB has also been shown to be a primary cause of death during pandemics, including the Spanish Influenza outbreak of 1918-1919. The majority of data has been obtained from mouse models, thus the aim of this study was to determine the impact of Flu co-infection on host immunity and disease severity in TB patients at diagnosis. Sputum from 282 patients with active TB were analyzed for presence of FluA/FluB RNA at presentation using multiplex PCR. Sputum RNA was also analyzed for (Mtb) load using S RNA amplification. Supernatants from digested sputum and Mtb antigen-stimulated whole blood were analyzed using multiplex cytokine arrays and PBMC were analyzed for cytokine production from CD4+ T, CD8+ T and Mucosal Associated Invariant T cells (MAITs). 12 (4.3%) of TB patients were found to have FluA or FluB viral RNA present in their sputum at the time of TB diagnosis. The TB/Flu co-infected patients had a significantly higher bacterial load compared to those with TB mono-infection ( = 0.0026). They had lower levels of IL17A in sputum ( = 0.0275) and higher MCP-1 (CCL2) levels in the blood following PPD stimulation ( = 0.0267). TB/Flu co-infected subjects had significantly higher IFN-γ+IL-17+CD4+ and IFN-γ+IL-17-CD8+ cells compared to TB mono-infected subjects. These data show that Flu co-infection at time of TB diagnosis is associated with a higher bacterial load and differential cellular and soluble profiles. These findings show for the first time the impact of TB/Flu co-infection in a human cohort and support the potential benefit of Flu vaccination in TB-endemic settings.
Background: Prior Influenza A viral (IAV) infection has been shown to increase susceptibility to tuberculosis (TB) and TB has also been shown to be a primary cause of death during pandemics, including the Spanish Influenza outbreak of 1918–1919. The majority of data has been obtained from mouse models, thus the aim of this study was to determine the impact of Flu co-infection on host immunity and disease severity in TB patients at diagnosis.Methods: Sputum from 282 patients with active TB were analyzed for presence of FluA/FluB RNA at presentation using multiplex PCR. Sputum RNA was also analyzed for Mycobacterium tuberculosis (Mtb) load using 16S RNA amplification. Supernatants from digested sputum and Mtb antigen-stimulated whole blood were analyzed using multiplex cytokine arrays and PBMC were analyzed for cytokine production from CD4+ T, CD8+ T and Mucosal Associated Invariant T cells (MAITs).Results: 12 (4.3%) of TB patients were found to have FluA or FluB viral RNA present in their sputum at the time of TB diagnosis. The TB/Flu co-infected patients had a significantly higher bacterial load compared to those with TB mono-infection (p = 0.0026). They had lower levels of IL17A in ex vivo sputum (p = 0.0275) and higher MCP-1 (CCL2) levels in the blood following PPD stimulation (p = 0.0267). TB/Flu co-infected subjects had significantly higher IFN-γ+IL-17+CD4+ and IFN-γ+IL-17-CD8+ cells compared to TB mono-infected subjects.Conclusions: These data show that Flu co-infection at time of TB diagnosis is associated with a higher bacterial load and differential cellular and soluble profiles. These findings show for the first time the impact of TB/Flu co-infection in a human cohort and support the potential benefit of Flu vaccination in TB-endemic settings.
Background: Prior Influenza A viral (IAV) infection has been shown to increase susceptibility to tuberculosis (TB) and TB has also been shown to be a primary cause of death during pandemics, including the Spanish Influenza outbreak of 1918–1919. The majority of data has been obtained from mouse models, thus the aim of this study was to determine the impact of Flu co-infection on host immunity and disease severity in TB patients at diagnosis. Methods: Sputum from 282 patients with active TB were analyzed for presence of FluA/FluB RNA at presentation using multiplex PCR. Sputum RNA was also analyzed for Mycobacterium tuberculosis (Mtb) load using 16 S RNA amplification. Supernatants from digested sputum and Mtb antigen-stimulated whole blood were analyzed using multiplex cytokine arrays and PBMC were analyzed for cytokine production from CD4+ T, CD8+ T and Mucosal Associated Invariant T cells (MAITs). Results: 12 (4.3%) of TB patients were found to have FluA or FluB viral RNA present in their sputum at the time of TB diagnosis. The TB/Flu co-infected patients had a significantly higher bacterial load compared to those with TB mono-infection ( p = 0.0026). They had lower levels of IL17A in ex vivo sputum ( p = 0.0275) and higher MCP-1 (CCL2) levels in the blood following PPD stimulation ( p = 0.0267). TB/Flu co-infected subjects had significantly higher IFN-γ+IL-17+CD4+ and IFN-γ+IL-17-CD8+ cells compared to TB mono-infected subjects. Conclusions: These data show that Flu co-infection at time of TB diagnosis is associated with a higher bacterial load and differential cellular and soluble profiles. These findings show for the first time the impact of TB/Flu co-infection in a human cohort and support the potential benefit of Flu vaccination in TB-endemic settings.
Author Kampmann, Beate
Heslop, Rhiannon
Sutherland, Jayne S.
Bojang, Adama L.
Jarju, Sheikh
Mendy, Joseph
AuthorAffiliation 1 Vaccines & Immunity Theme, MRC Unit The Gambia at the London School of Hygiene & Tropical Medicine , Banjul , Gambia
2 Faculty of Biosciences, The University of Manchester , Manchester , United Kingdom
AuthorAffiliation_xml – name: 1 Vaccines & Immunity Theme, MRC Unit The Gambia at the London School of Hygiene & Tropical Medicine , Banjul , Gambia
– name: 2 Faculty of Biosciences, The University of Manchester , Manchester , United Kingdom
Author_xml – sequence: 1
  givenname: Joseph
  surname: Mendy
  fullname: Mendy, Joseph
– sequence: 2
  givenname: Sheikh
  surname: Jarju
  fullname: Jarju, Sheikh
– sequence: 3
  givenname: Rhiannon
  surname: Heslop
  fullname: Heslop, Rhiannon
– sequence: 4
  givenname: Adama L.
  surname: Bojang
  fullname: Bojang, Adama L.
– sequence: 5
  givenname: Beate
  surname: Kampmann
  fullname: Kampmann, Beate
– sequence: 6
  givenname: Jayne S.
  surname: Sutherland
  fullname: Sutherland, Jayne S.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30662443$$D View this record in MEDLINE/PubMed
BookMark eNp1kk1vEzEQhi1UREvonRPykcsGf2f3ggThK1IRB4I4Wl7vOHHZtcvaixR-Pd6kVC0SPtiW_c4zY8_7FJ2FGACh55QsOa-bV84Pw7RkhNZLwknDH6ELqpSoOGPi7N7-HF2mdE3KEA3nXD5B55woxYTgF-jHem_CDhL2AX8-2Ngam2H004Dz1MJopz4mn6qvN2C98xZvSs7g8wF_93mPN8H1E4TfBttY-eDAZh8DNhlv_QA4Orx9i995swsz5Rl67Eyf4PJ2XaBvH95v15-qqy8fN-s3V5UViuWKyVKbMoqoGlhtO8rEPBGqmHMrWYtGECFZY0ExIy1fSeCNocBbbuSKA1-gzYnbRXOtb0Y_mPGgo_H6eBDHnTZj9rYH7Rx1BdYRK41QYFrZSSpryrq6nX-ssF6fWDdTO0BnIeTR9A-gD2-C3-td_KUVZ7Uo5SzQy1vAGH9OkLIefLLQ9yZAnJJmdDW_h8i6SF_cz3WX5G-3ioCcBHaMKY3g7iSU6NkT-ugJPXtCHz1RQtQ_IdZnM3epVOv7_wf-Ad76vJ8
CitedBy_id crossref_primary_10_1007_s11274_023_03636_x
crossref_primary_10_1038_s41590_019_0444_8
crossref_primary_10_2174_2666796703666220705144250
crossref_primary_10_3389_fimmu_2023_1240419
crossref_primary_10_1038_s41467_022_30914_3
crossref_primary_10_1038_s41541_020_0189_2
crossref_primary_10_1007_s15010_021_01576_y
crossref_primary_10_2478_jtim_2020_0010
crossref_primary_10_1016_j_mehy_2019_109505
crossref_primary_10_1371_journal_ppat_1010093
crossref_primary_10_7717_peerj_7443
crossref_primary_10_1126_scisignal_abe1621
crossref_primary_10_1186_s12879_020_05194_1
crossref_primary_10_1016_j_it_2024_07_008
crossref_primary_10_1128_CMR_00094_21
crossref_primary_10_1002_1873_3468_13488
crossref_primary_10_1016_j_virs_2025_03_005
crossref_primary_10_1055_s_0042_1760409
crossref_primary_10_1097_EC9_0000000000000039
crossref_primary_10_1002_ppul_27232
crossref_primary_10_3390_jcm14072154
Cites_doi 10.4049/jimmunol.1401088
10.1016/j.coi.2013.03.011
10.1186/s12879-015-0746-x
10.1189/jlb.1211619
10.2807/ese.14.42.19369-en
10.1093/infdis/jit424
10.1371/journal.pone.0129173
10.1038/nri2960
10.1038/nature09247
10.1126/science.1233665
10.1371/journal.pone.0168272
10.1371/journal.pone.0008459
10.3201/eid2403.152071
10.4049/jimmunol.1202824
10.1016/j.vaccine.2011.02.053
10.1038/nri3166
ContentType Journal Article
Copyright Copyright © 2019 Mendy, Jarju, Heslop, Bojang, Kampmann and Sutherland. 2019 Mendy, Jarju, Heslop, Bojang, Kampmann and Sutherland
Copyright_xml – notice: Copyright © 2019 Mendy, Jarju, Heslop, Bojang, Kampmann and Sutherland. 2019 Mendy, Jarju, Heslop, Bojang, Kampmann and Sutherland
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOA
DOI 10.3389/fimmu.2018.03093
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals (ODIN)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE


Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1664-3224
ExternalDocumentID oai_doaj_org_article_ff1f045d0c5a46eab5d515812d8b0000
PMC6328457
30662443
10_3389_fimmu_2018_03093
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations Gambia
GeographicLocations_xml – name: Gambia
GrantInformation_xml – fundername: Medical Research Council
  grantid: MC_UP_A900_1122
– fundername: Medical Research Council
  grantid: MC_EX_MR/K011944/1
– fundername: Medical Research Council
  grantid: MC_UU_00026/2
– fundername: Medical Research Council
  grantid: MC_EX_MR/P024270/1
– fundername: Medical Research Council
  grantid: MC_U190071468
GroupedDBID 53G
5VS
9T4
AAFWJ
AAKDD
AAYXX
ACGFO
ACGFS
ACXDI
ADBBV
ADRAZ
AENEX
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
CITATION
DIK
EBS
EMOBN
GROUPED_DOAJ
GX1
HYE
KQ8
M48
M~E
OK1
PGMZT
RNS
RPM
CGR
CUY
CVF
ECM
EIF
IPNFZ
NPM
RIG
7X8
5PM
ID FETCH-LOGICAL-c462t-256246a6068e28cd124cd120162ff75849404529ce62a5c375e39a1e3b3a573e3
IEDL.DBID M48
ISSN 1664-3224
IngestDate Wed Aug 27 01:30:41 EDT 2025
Thu Aug 21 18:30:25 EDT 2025
Fri Sep 05 13:14:19 EDT 2025
Sat May 31 02:14:06 EDT 2025
Tue Jul 01 01:35:40 EDT 2025
Thu Apr 24 23:01:14 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords influenza
cytokines
flow cytometry
bacterial load
tuberculosis
Language English
License This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c462t-256246a6068e28cd124cd120162ff75849404529ce62a5c375e39a1e3b3a573e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
This article was submitted to Microbial Immunology, a section of the journal Frontiers in Immunology
Edited by: Christoph Hölscher, Forschungszentrum Borstel (LG), Germany
Reviewed by: Bianca Schneider, Forschungszentrum Borstel (LG), Germany; Warwick Britton, University of Sydney, Australia
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3389/fimmu.2018.03093
PMID 30662443
PQID 2179404058
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_ff1f045d0c5a46eab5d515812d8b0000
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6328457
proquest_miscellaneous_2179404058
pubmed_primary_30662443
crossref_primary_10_3389_fimmu_2018_03093
crossref_citationtrail_10_3389_fimmu_2018_03093
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2019-01-04
PublicationDateYYYYMMDD 2019-01-04
PublicationDate_xml – month: 01
  year: 2019
  text: 2019-01-04
  day: 04
PublicationDecade 2010
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
PublicationTitle Frontiers in immunology
PublicationTitleAlternate Front Immunol
PublicationYear 2019
Publisher Frontiers Media S.A
Publisher_xml – name: Frontiers Media S.A
References Walzl (B6) 2011; 11
Redford (B9) 2014; 209
Flórido (B12) 2013; 191
Yen (B13) 2018; 24
Pasman (B1) 2012; 85
McNab (B10) 2014; 193
Braciale (B8) 2012; 12
Heslop (B15) 2016; 11
Kumar (B14) 2013; 25
Walaza (B4) 2015; 10
Hasan (B16) 2009; 4
Archer (B3) 2009; 14
Walaza (B5) 2015; 15
Jurado (B17) 2012; 91
Teles (B11) 2013; 339
Berry (B7) 2010; 466
Noymer (B2) 2011; 29
References_xml – volume: 193
  start-page: 3600
  year: 2014
  ident: B10
  article-title: Type I IFN induces IL-10 production in an IL-27-independent manner and blocks responsiveness to IFN-γ for production of IL-12 and bacterial killing in Mycobacterium tuberculosis-infected macrophages
  publication-title: J Immunol.
  doi: 10.4049/jimmunol.1401088
– volume: 25
  start-page: 373
  year: 2013
  ident: B14
  article-title: Th17 cell-based vaccines in mucosal immunity
  publication-title: Curr Opin Immunol.
  doi: 10.1016/j.coi.2013.03.011
– volume: 15
  start-page: 26
  year: 2015
  ident: B5
  article-title: Influenza virus infection is associated with increased risk of death amongst patients hospitalized with confirmed pulmonary tuberculosis in South Africa, 2010–2011
  publication-title: BMC Infect Dis.
  doi: 10.1186/s12879-015-0746-x
– volume: 91
  start-page: 991
  year: 2012
  ident: B17
  article-title: IL-17 and IFN-γ expression in lymphocytes from patients with active tuberculosis correlates with the severity of the disease
  publication-title: J Leukoc Biol.
  doi: 10.1189/jlb.1211619
– volume: 14
  start-page: 19369
  year: 2009
  ident: B3
  article-title: Interim report on pandemic H1N1 influenza virus infections in South Africa, April to October 2009: epidemiology and factors associated with fatal cases
  publication-title: Euro Surveill.
  doi: 10.2807/ese.14.42.19369-en
– volume: 85
  start-page: 127
  year: 2012
  ident: B1
  article-title: The complication of coinfection
  publication-title: Yale J Biol Med.
– volume: 209
  start-page: 270
  year: 2014
  ident: B9
  article-title: Influenza A virus impairs control of Mycobacterium tuberculosis coinfection through a Type I interferon receptor-dependent pathway
  publication-title: J Infect Dis.
  doi: 10.1093/infdis/jit424
– volume: 10
  start-page: e0129173
  year: 2015
  ident: B4
  article-title: Excess mortality associated with influenza among tuberculosis deaths in South Africa, 1999–2009
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0129173
– volume: 11
  start-page: 343
  year: 2011
  ident: B6
  article-title: Immunological biomarkers of tuberculosis
  publication-title: Nat Rev Immunol.
  doi: 10.1038/nri2960
– volume: 466
  start-page: 973
  year: 2010
  ident: B7
  article-title: An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis
  publication-title: Nature
  doi: 10.1038/nature09247
– volume: 339
  start-page: 1448
  year: 2013
  ident: B11
  article-title: Type I interferon suppresses Type II interferon-triggered human anti-mycobacterial responses
  publication-title: Science
  doi: 10.1126/science.1233665
– volume: 11
  start-page: e0168272
  year: 2016
  ident: B15
  article-title: Changes in host cytokine patterns of TB patients with different bacterial loads detected using 16S rRNA analysis
  publication-title: Plos ONE
  doi: 10.1371/journal.pone.0168272
– volume: 4
  start-page: e8459
  year: 2009
  ident: B16
  article-title: CCL2 responses to Mycobacterium tuberculosis are associated with disease severity in tuberculosis
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0008459
– volume: 24
  start-page: 498
  year: 2018
  ident: B13
  article-title: Influenza vaccination and incident tuberculosis among elderly persons, Taiwan
  publication-title: Emerg Infect Dis.
  doi: 10.3201/eid2403.152071
– volume: 191
  start-page: 302
  year: 2013
  ident: B12
  article-title: Influenza A virus infection impairs mycobacteria-specific T cell responses and mycobacterial clearance in the lung during pulmonary coinfection
  publication-title: J Immunol.
  doi: 10.4049/jimmunol.1202824
– volume: 29
  start-page: B38
  year: 2011
  ident: B2
  article-title: The 1918 influenza pandemic hastened the decline of tuberculosis in the United States: an age, period, cohort analysis
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2011.02.053
– volume: 12
  start-page: 295
  year: 2012
  ident: B8
  article-title: Regulating the adaptive immune response to respiratory virus infection
  publication-title: Nat Rev Immunol.
  doi: 10.1038/nri3166
SSID ssj0000493335
Score 2.3415596
Snippet Prior Influenza A viral (IAV) infection has been shown to increase susceptibility to tuberculosis (TB) and TB has also been shown to be a primary cause of...
Background: Prior Influenza A viral (IAV) infection has been shown to increase susceptibility to tuberculosis (TB) and TB has also been shown to be a primary...
Background: Prior Influenza A viral (IAV) infection has been shown to increase susceptibility to tuberculosis (TB) and TB has also been shown to be a primary...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 3093
SubjectTerms Adult
Bacterial Load
Cohort Studies
Coinfection - blood
Coinfection - diagnosis
Coinfection - immunology
Coinfection - microbiology
cytokines
DNA, Bacterial - isolation & purification
Female
flow cytometry
Gambia
Humans
Immunology
influenza
Influenza A virus - genetics
Influenza A virus - immunology
Influenza A virus - isolation & purification
Influenza B virus - genetics
Influenza B virus - immunology
Influenza B virus - isolation & purification
Influenza, Human - blood
Influenza, Human - diagnosis
Influenza, Human - immunology
Influenza, Human - virology
Male
Mycobacterium tuberculosis - genetics
Mycobacterium tuberculosis - immunology
Mycobacterium tuberculosis - isolation & purification
RNA, Ribosomal, 16S - genetics
RNA, Viral - isolation & purification
Sputum - microbiology
tuberculosis
Tuberculosis, Pulmonary - blood
Tuberculosis, Pulmonary - diagnosis
Tuberculosis, Pulmonary - immunology
Tuberculosis, Pulmonary - microbiology
Young Adult
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals (ODIN)
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LS8QwEA4iCF7Et-uLCF48xN1tkj6OPlFBT4reQpImWHVbse1h_fVOkt1lV0QvXnpoUzrMTDLfNJNvEDpMM2n7acxIIhknjOYxUYr3iKQ9E6ksAojuqy3u4qsHdvPEn6ZafbmasEAPHBTXtbZvAXbkPc0li41UPIcQDGEpTz3AcasvhLGpZOol4F5KKQ_7kpCFZV1bDAatK-VKj_3u30wc8nT9P2HM76WSU7HnchktjUAjPgnCrqA5U66ihdBGcriGXsMRgRoXJb4dapihnoG5HeCmVeZDt29VXdTEt5q3hcbX_kxIM8SPRfOMr0Obkk-JdUXGtVkllg12x0NwZfH9KT4PFXlFvY4eLi_uz67IqIkC0SyOGgKQJmKxhDwlNVGqc4jn7gJIL7IWkgWWMceqnmkTR5JrmnBDM9k3VFHJE2roBpovq9JsIWyNhfltrALNsiQBezDILy0gzLyfKK47qDtWqdAjhnHX6OJNQKbhjCC8EYQzgvBG6KCjyRvvgV3jl7GnzkqTcY4X298AbxEjbxF_eUsHHYxtLGAeuc0RWZqqrUXkViZY0XjaQZvB5pNPUUeTzxiIkMx4w4wss0_K4tlzdccU4j9Ptv9D-B20COrI_A8gtovmm4_W7AEkatS-9_4v6GcJrQ
  priority: 102
  providerName: Directory of Open Access Journals
Title Changes in Mycobacterium tuberculosis-Specific Immunity With Influenza co-infection at Time of TB Diagnosis
URI https://www.ncbi.nlm.nih.gov/pubmed/30662443
https://www.proquest.com/docview/2179404058
https://pubmed.ncbi.nlm.nih.gov/PMC6328457
https://doaj.org/article/ff1f045d0c5a46eab5d515812d8b0000
Volume 9
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1664-3224
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000493335
  issn: 1664-3224
  databaseCode: KQ8
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 1664-3224
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000493335
  issn: 1664-3224
  databaseCode: DOA
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 1664-3224
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000493335
  issn: 1664-3224
  databaseCode: DIK
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVFQY
  databaseName: GFMER Free Medical Journals
  customDbUrl:
  eissn: 1664-3224
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000493335
  issn: 1664-3224
  databaseCode: GX1
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php
  providerName: Geneva Foundation for Medical Education and Research
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 1664-3224
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000493335
  issn: 1664-3224
  databaseCode: M~E
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVAQN
  databaseName: PubMed Central (Free e-resource, activated by CARLI)
  customDbUrl:
  eissn: 1664-3224
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000493335
  issn: 1664-3224
  databaseCode: RPM
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
– providerCode: PRVFZP
  databaseName: Scholars Portal Journals: Open Access
  customDbUrl:
  eissn: 1664-3224
  dateEnd: 20250131
  omitProxy: true
  ssIdentifier: ssj0000493335
  issn: 1664-3224
  databaseCode: M48
  dateStart: 20101001
  isFulltext: true
  titleUrlDefault: http://journals.scholarsportal.info
  providerName: Scholars Portal
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwELZKERIXxJttoTISQuLgduNXkgNCFCgtUjl1xd4sx7HbwG7SbhKJ5dcztrMrFq0QFx8SJ37M2P7GHs-H0Kss1y7JJCep5oJwVkpSFGJMNBtbWuQUIHrwtvgqTyf8y1RMd9DqdsnQge1W087zSU0Ws8OfN8t3MODfeosT1tsjV83nvffSyg7Dwd7r6xviaaX88evAsXEL3Yalinq1Px_w__cIjxkLJJyJhPqCcvN4lLn1vxtLV4jwvw2W_u1d-cdydXIf3RtwJn4fFeMB2rH1Q3QnMk8uH6Ef8VZBi6sany8NDOoQtLmf464v7ML0s6atWhLY6V1l8Fm4RtIt8bequ8Jnkdnkl8amISt3rhrrDvsbJbhx-OIYf4xOfFX7GE1OPl18OCUD7wIxXNKOAAqiXGowbTJLM1MCBPAJgEPqHNgXPOc-EHturKRaGJYKy3KdWFYwLVJm2RO0Wze1fYawsw6mBOsK6GWepkKDNUiFA1BaJmkhzAgdrbpUmSEouefGmCkwTrwQVBCC8kJQQQgj9Gb9xXUMyPGPvMdeSut8PpR2eNAsLtUwMpVziYPmlGMDtZNWF6IEjAe4p8wCgh6hlysZKxh6_jxF17bpW0X9ZAaToMhG6GmU-boo5iPrcw5VSDe0YaMum2_q6iqE95YMIINI9_6j3H10F1qbhy0h_hztdovevgCQ1BUHYXMB0s_T5CAo_W-ciRJI
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Changes+in+Mycobacterium+tuberculosis-Specific+Immunity+With+Influenza+co-infection+at+Time+of+TB+Diagnosis&rft.jtitle=Frontiers+in+immunology&rft.au=Mendy%2C+Joseph&rft.au=Jarju%2C+Sheikh&rft.au=Heslop%2C+Rhiannon&rft.au=Bojang%2C+Adama+L&rft.date=2019-01-04&rft.issn=1664-3224&rft.eissn=1664-3224&rft.volume=9&rft.spage=3093&rft_id=info:doi/10.3389%2Ffimmu.2018.03093&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1664-3224&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1664-3224&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1664-3224&client=summon